Ensysce Biosciences (ENSC) executive compensation, 2025 proxy

Dr. Lynn Kirkpatrick, PhD., Chief Executive Officer, was paid $442,392 in 2024, down 13% from $508,575 the year before.

Filed
December 2, 2025
Annual meeting
December 23, 2025
Pay year
2024
Named executives
3
CEO total pay
$442,392-13% vs prior year
CEO Target Bonus
50%Percentage of base salary
NEO Target Bonus
30%Percentage of base salary for CFO and CCO
401(k) Match
3%Employer contribution rate
Plan Share Increase
721,457Proposed total shares under incentive plan

How PhD. was paid

$442,392 in total for 2024, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary98%All other compensation2%

Named executive officers

ExecutiveTotal
Dr. Lynn Kirkpatrick, PhD.Chief Executive Officer$442,392
Dave HumphreyChief Financial Officer$371,267
Geoff BirkettChief Commercial Officer$343,634

What changed and why

  • $442KCEO total compensation decreased to $442,392 in fiscal 2024 from $508,575 in fiscal 2023.
  • 5%Base salaries for executive officers received a 5% cost of living increase effective March 1, 2025.
  • 50%Annual bonuses are targeted at 50% of base salary for the CEO and 30% for other NEOs.
  • 3%All other compensation consists solely of 401(k) matching contributions of 3% of eligible compensation.
  • Proposal Two seeks to increase shares reserved under the 2021 Omnibus Incentive Plan from 121,457 to 721,457.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.